Comportamiento de tipo A (propenso a la coronaria) en diabéticos.

Determining the Compliance of the Sysmex XR-1000 Haematology Analyser With WADA Athlete Biological Passport Specifications.

Drug testing and analysis·2025

Transcriptomic characterization of transitioning cell types in the skin of Atlantic salmon.

BMC biology·2025

Keratinocytes drive the epithelial hyperplasia key to sea lice resistance in coho salmon.

BMC biology·2024

Improving the capacity of researchers and bereaved parents to co-design and translate stillbirth research together.

Women and birth : journal of the Australian College of Midwives·2023

Crevasse refreezing and signatures of retreat observed at Kamb Ice Stream grounding zone.

Nature geoscience·2023

Expression of type I interferon-associated genes at antiretroviral therapy interruption predicts HIV virological rebound.

Scientific reports·2022

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Lancet (London, England)·2026

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Lancet (London, England)·2026

Advancing the relevance of clinical trials for older patients.

Lancet (London, England)·2026

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Lancet (London, England)·2026

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Lancet (London, England)·2026

Multifactorial Chylomicronemia Syndrome With a Rare APOA5 Variant and Recurrent Acute Pancreatitis: A Case Report From Rural Colombia.

Cureus·2026

Culturally Meaningful End-of-Life Care for a Patient With Cancer of Unknown Primary, and Severe Motor and Intellectual Disabilities: A Case Report.

Cureus·2026

The glioblastoma ecosystem: clonal evolution, heterogeneity, and therapeutic resistance.

Frontiers in cell and developmental biology·2026

Harnessing AI-driven approaches for detecting metabolic dysfunction-associated steatotic liver disease, assessing fibrosis, and stratifying hepatocellular carcinoma risk: a scoping review.

Frontiers in oncology·2026

The gut microbiota in colorectal cancer: role in cytokine regulation, intestinal immune barrier dysfunction.

Frontiers in oncology·2026

The role and application prospects of glycolysis-related non-coding RNAs in lung cancer.

Journal of translational medicine·2026

Videos de Experimentos Relacionados

Comportamiento de tipo A (propenso a la coronaria) en diabéticos

Videos de Conceptos Relacionados

Determining the Compliance of the Sysmex XR-1000 Haematology Analyser With WADA Athlete Biological Passport Specifications.

Transcriptomic characterization of transitioning cell types in the skin of Atlantic salmon.

Keratinocytes drive the epithelial hyperplasia key to sea lice resistance in coho salmon.

Improving the capacity of researchers and bereaved parents to co-design and translate stillbirth research together.

Crevasse refreezing and signatures of retreat observed at Kamb Ice Stream grounding zone.

Expression of type I interferon-associated genes at antiretroviral therapy interruption predicts HIV virological rebound.

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Advancing the relevance of clinical trials for older patients.

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Multifactorial Chylomicronemia Syndrome With a Rare APOA5 Variant and Recurrent Acute Pancreatitis: A Case Report From Rural Colombia.

Culturally Meaningful End-of-Life Care for a Patient With Cancer of Unknown Primary, and Severe Motor and Intellectual Disabilities: A Case Report.

The glioblastoma ecosystem: clonal evolution, heterogeneity, and therapeutic resistance.

Harnessing AI-driven approaches for detecting metabolic dysfunction-associated steatotic liver disease, assessing fibrosis, and stratifying hepatocellular carcinoma risk: a scoping review.

The gut microbiota in colorectal cancer: role in cytokine regulation, intestinal immune barrier dysfunction.

The role and application prospects of glycolysis-related non-coding RNAs in lung cancer.

Videos de Experimentos Relacionados

Comportamiento de tipo A (propenso a la coronaria) en diabéticos

Videos de Conceptos Relacionados

Artículos Relacionados